Nanoscale Immune Activator for Enhancing CD8+ T Cell Infiltration in Hepatocellular Carcinoma
These findings establish HCC-IN-247 as an activator of the tumor immune microenvironment and provide a preclinical basis for a combined immunotherapeutic approach to HCC.